SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc

Ultragenyxs full FDA approval of Fayuvi (UX111), the first approved treatment for Sanfilippo syndrome type A, is driving attention, with traders highlighting its commercial launch potential and accompanying Priority Review Voucher. The community is broadly bullish but debating whether the muted share-price reaction reflects profit-taking, short interest, limited patient volume, or concerns about cash burn and commercialization.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

A sharp rally has focused attention on NEARs AI-agent, cross-chain Intents and privacy-trading narrative, with traders citing fee-driven token demand and a reported confidential-perpetuals launch on Hyperliquid. The community is divided between those viewing the move as adoption-driven and those attributing it to whale activity, short covering and a liquidity-led pump with no confirmed news catalyst.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

Anticipation of SpaceXs Starship Flight 14, now targeted for Sept. 28, is the dominant catalyst, with traders debating whether a successful test could strengthen momentum and trigger short covering. Bears remain focused on repeated launch delays, elevated valuation, and upcoming lockup-related share supply, while NASAs selection of SpaceX for the StarBurst launch mission adds supporting contract news.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

A second fiscal 2026 guidance reduction, driven by continued delays ramping the Houston contract-manufacturing facility, has intensified concerns about Fluences execution, delivery timing and profitability despite reported strong demand and backlog. Traders are divided between those questioning management credibility and expecting further downside, and dip buyers who view the new AES-linked COO and operational restructuring as potential fixes.

Generac Holdings, Inc. engages in the business of designing and manufacturing energy technology solutions. It operates under the Domestic and International segments. The Domestic segment includes the legacy Generac business and the acquisitions that are based in the United States and Canada. The International segment focuses on Generac business' Latin American export operations. The company was founded in 1959 and is headquartered in Waukesha, WI.

Generac Holdings Inc

A long-term Amazon supply agreement for backup generators at data centers has repositioned Generac as an AI infrastructure and power-demand play, driving a sharp rally and bullish discussion about stronger revenue visibility and additional hyperscaler deals. Traders are also debating profit-taking, warrant dilution, valuation, and whether the initial gap was overextended, with some viewing the pullback as consolidation rather than a change in the catalyst.

Ethena is a delta-hedged synthetic dollar with native crypto yield derived from staking and perpetual funding rate

Ethena USDe

Ethena ecosystem momentumparticularly ENA price strength, treasury exposure, and expanding stablecoin infrastructureis driving attention, with traders viewing USDe as a proxy for the broader stablecoin trade. The conversation remains speculative, with bullish momentum trading offset by concerns about valuation, dilution, and governance.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Labs completion of its equity offering to fully fund the pending Iridium acquisition, alongside continued Neutron hardware testing, is driving attention. Traders view the financing milestone as removing a dilution overhang, while debate remains over the acquisitions pending approvals, Neutron delays, and broader rate-driven pressure on high-growth stocks.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxs completed acquisition of Chain Technology and Services, along with the launch of Onyx Mesh and planned wallet card functionality, is driving attention as traders focus on payment rails, stablecoins, banking integrations and a potential neobank ecosystem. The community is largely bullish on the expanded infrastructure and XCN utility, though skeptics argue the announcements have produced pump-and-dump activity and insufficient evidence of real adoption.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

The Senates failure to advance the Crypto CLARITY Act has driven intense debate around MSTR and other Bitcoin-linked stocks, with traders split between viewing the setback as priced in or irrelevant to Bitcoin and expecting further downside. Rate-hike concerns, Bitcoin weakness, and ongoing dilution are adding to bearish arguments, while bulls continue to frame the volatility as a buying opportunity and potential short squeeze.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

IBRX is drawing attention after an unusually high-volume rally without a confirmed company-specific announcement, prompting speculation about institutional accumulation, short covering, and a possible technical breakout. Traders are divided between viewing the move as momentum tied to broader biotech strength and expecting upcoming Anktiva-related regulatory or clinical updates, versus warning that it may fade like prior rallies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
